Stephen Mayer

Stephen Mayer possesses extensive financial expertise demonstrated through various roles at AbbVie. Serving from January 2013 to June 2018, Stephen held positions including Site Controller, where responsibilities involved overseeing financial operations at AbbVie Biopharmaceutical Company, and progressing to Financial Controller, Director, and Senior Director, Assistant Treasurer. In these roles, Stephen led debt capital markets, strategic hedging initiatives, and financial planning for AbbVie’s Treasury function, notably issuing $30 billion in investment-grade notes for the Allergan acquisition and managing a $10 billion net investment hedge portfolio to significantly reduce the company's debt costs.